• 1
    Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 17786.
  • 2
    Lau DT, Kasper JD, Potter DEB, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005; 165: 6874.
  • 3
    Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 17384.
  • 4
    O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008; 37: 13841.
  • 5
    Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994; 47: 8916.
  • 6
    Fialova D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 2009; 67: 6415.
  • 7
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003:163: 271624.
  • 8
    McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 38591.
  • 9
    Naugler CT, Brymer C, Stolee P, Arcese ZA. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000; 7: 1037.
  • 10
    Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34: 33846.
  • 11
    Aparasu RR, Mort JR. Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am J Geriatr Pharmacother 2004; 2: 10211.
  • 12
    Van Der Hooft CS, Jong GW't, Dieleman JP, Verhamme KMC, Van Der Cammen TJM, Stricker BHC, Sturkenboom MCJM. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria – a population-based cohort study. Br J Clin Pharmacol 2005; 60: 13744.
  • 13
    Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 134858.
  • 14
    Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 7283.
  • 15
    Carey IM, De Wilde S, Harris T, Victor C, Richards N, Hilton SR, Cook DG. What factors predict potentially inappropriate primary care prescribing in older people? Drugs Aging 2008; 25: 639706.
  • 16
    De Wilde S, Carey IM, Harris T, Richards N, Victor C, Hilton SR, Cook DG. Trends in potentially inappropriate prescribing amongst older UK primary care patients. Pharmacoepidemiol Drug Saf 2007; 16: 65867.
  • 17
    Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002; 42: 84757.
  • 18
    Naughton C, Bennett K, Feely J. Prevalence of chronic disease in the elderly based on a national pharmacy claims database. Age Ageing 2006; 35: 6336.
  • 19
    WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, 2007.
  • 20
    Ryan C, O'Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother 2009; 43: 123944.
  • 21
    Gray J, Majeed A, Kerry S, Rowlands G. Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. BMJ 2000; 321: 54850.
  • 22
    Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164: 30512.
  • 23
    Aronson JK. In defence of polypharmacy. Br J Clin Pharmacol 2004; 57: 11920.
  • 24
    Health Services Executive (HSE). Primary care reimbursement services: statistical analysis of claims and payments. Dublin, Ireland: Health Services Executive (HSE), 2007.
  • 25
    NICE. Guidance on the use of proton pump inhibitors in the treatment of dyspepsia. Technology appraisal guidance. 2000: 7.
  • 26
    Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008; 336: 23.
  • 27
    Choudhry MN, Soran H, Ziglam HM. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. QJM 2008; 101: 4458.
  • 28
    Yang Y-X, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296: 294753.
  • 29
    Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 159.
  • 30
    Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 13647.
  • 31
    De Smet PAGM, Wilma D, Kramers C, Grol R. A composite screening tool for medication reviews of outpatients. Drugs Aging 2007; 24: 73360.
  • 32
    Tinetti ME. Preventing falls in elderly persons. N Engl J Med 2003; 348: 429.
  • 33
    Krol N, Wensing M, Haaijer-Ruskamp F, Muris JWM, Numans ME, Schattenberg G, Van Balen J, Grol R. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial. Aliment Pharmacol Ther 2004; 19: 91722.
  • 34
    Messier S, Legault C, Mihalko S, Miller G, Loeser R, DeVita P, Lyles M, Eckstein F, Hunter DJ, Williamson JD, Nicklas BJ. The Intensive Diet and Exercise for Arthritis (IDEA) Trial: design and rationale. BMC Musculoskelet Disord 2009; 10: 93.
  • 35
    Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004; 329: 3249.
  • 36
    Haumschild MJ, Karfonta TL, Haumschild MS, Phillips SE. Clinical and economic outcomes of a fall-focused pharmaceutical intervention program. Am J Health Syst Pharm 2003; 60: 102932.
  • 37
    Gorgels WJMJ, Oude Voshaar RC, Mol AJJ, Van De Lisdonk EH, Van Balkom AJLM, Van Den Hoogen HJM, Mulder J, Breteler MHM, Zitman FG. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend 2005; 78: 4956.
  • 38
    Batty GM, Oborne CA, Swift CG, Jackson SHD. Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical in-patients. Int J Geriatr Psychiatry 2000; 15: 8926.
  • 39
    Agostini JV. Measuring drug burden: a step forward. Arch Intern Med 2007; 167: 7534.
  • 40
    Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT, Kamberg CJ, MacLean CH, Young RT, Adams J, Reuben DB, Avorn J, Wenger NS. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004; 140: 71420.
  • 41
    Kuijpers MAJ, Van Marum RJ, Egberts ACG, Jansen PAF. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 1303.
  • 42
    Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 6739.
  • 43
    Fillenbaum GG, Hanlon JT, Landerman LR, Artz MB, O'Connor H, Dowd B, Gross CR, Boult C, Garrard J, Schmader KE. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother 2004; 2: 92101.
  • 44
    Page RL II, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006; 4: 297305.